13F Pro

Lunate Capital Ltd

Institutional InvestorSimilar funds →SEC EDGAR: CIK 2056786
Institutional-grade research for retail investors

13F Reported Value

ⓘ

$120.4M

Holdings

6

Latest Filing

2026-03-31

Filing Quarter

Q1 2026

Portfolio Overview

Lunate Capital Ltd disclosed 6 positions worth $120.4M in its Form 13F-HR for Q1 2026, led by $RVMD (Revolution Medicines, Inc.) at 44.4% of the equity portfolio, followed by $SAIL and $LINE. The portfolio is most concentrated in Healthcare (48.5% of disclosed assets). All figures are sourced directly from Lunate Capital Ltd’s Form 13F-HR filing with the SEC under CIK 2056786.

AI Fund Analysis

Stable
RVMD$RVMD
44.4% weight
Held 5 quarters
SAIL$SAIL
33.0% weight
Held 5 quarters
LINE$LINE
16.3% weight
Held 5 quarters
NMRA$NMRA
3.4% weight
Held 5 quarters
RVMD$RVMD
0.7% weight
Held 4 quarters

Sector Allocation

HealthcareTechnologyReal Estate

AUM History

Top Equity Holdings by Value

Quarterly Activity — Q1 2026

Click any card to unlock

Top Holdings

AI Quality Scored

Unlock AI quality scores for every holding

32-signal composite ranking on each of Lunate Capital Ltd's 6 positions.

Showing top 6 of 6 holdings.

Sector Allocation

Healthcare

$58.3M

Technology

$42.4M

Real Estate

$19.7M

Full Holdings — Lunate Capital Ltd (Q1 2026)

All 6 disclosed positions from the latest Form 13F-HR, with quarter-over-quarter share changes and 13F Pro quality scores. Sourced from SEC EDGAR.

#TickerCompanyValueWeightQoQQuality
1RVMD$RVMDRevolution Medicines, Inc.$53.4M44.4%-75%—
2SAIL$SAILSailPoint, Inc.$39.7M33.0%+0%29.5
3LINE$LINELineage, Inc.$19.7M16.3%+0%37.5
4NMRA$NMRANeumora Therapeutics, Inc.$4.1M3.4%+0%—
5NAVN$NAVNNavan, Inc.$2.6M2.2%+0%—
6RVMD$RVMDRevolution Medicines, Inc.$805,5000.7%+0%—

Browse Top Institutional Investors

13F Pro tracks 8,700+ institutional investors filing 13F reports with the SEC.

Berkshire HathawayBridgewater AssociatesCitadel AdvisorsRenaissance TechnologiesTwo Sigma InvestmentsDE Shaw & CoMillennium ManagementAQR Capital ManagementPoint72 Asset ManagementTiger Global ManagementVanguard GroupBlackRock

to search all 8,700+ institutional filers.

Available Analysis

13F Pro tracks comprehensive institutional data for Lunate Capital Ltd including:

Full 13F portfolio with all holdings
Quarter-over-quarter position changes
Accumulation & distribution patterns
Sector allocation breakdown
Historical portfolio evolution
New positions & complete exits
Concentration analysis
Peer comparison with similar funds
AI-powered portfolio insights

Track Lunate Capital Ltd's Full Portfolio

See every holding, quarter-over-quarter changes, sector allocation, and accumulation patterns for Lunate Capital Ltd and 8,700+ other institutional investors.

View Pricing

Free tier includes full 13F search and fund profiles. Pro starts at $6.67/mo (billed annually).

Passwordless sign-in · Payments by Stripe · Auth by Clerk

AI-Powered Hedge Fund Analysis: Lunate Capital Ltd

13F Pro is an AI hedge fund tracker and stock research platform. For Lunate Capital Ltd (SEC CIK: 2056786), the platform ingests every quarterly Form 13F filing and applies AI-powered analysis on top — 10 specialized AI analysts (value, growth, momentum, macro, activist, and more) debate the fund's top positions and publish AI-generated analysis with cited SEC sources.

Every holding in Lunate Capital Ltd's portfolio is scored on a 32-signal AI quality ranking (ROIC, FCF margin, revenue growth, institutional flow, earnings quality, shareholder dilution, and more). Track accumulation and distribution quarter over quarter, identify conviction positions, and see AI stock analysis for each position — alongside 8,700+ other institutional filers and 2,800+ AI-ranked companies.